Literature DB >> 22340775

The impact of paradoxical comorbidities on risk-adjusted mortality of Medicare beneficiaries with cardiovascular disease.

Mary S Vaughan-Sarrazin1, Xin Lu, Peter Cram.   

Abstract

BACKGROUND: Persistent uncertainty remains regarding assessments of patient comorbidity based on administrative data for mortality risk adjustment. Some models include comorbid conditions that are associated with improved mortality while other models exclude these so-called paradoxical conditions. The impact of these conditions on patient risk assessments is unknown.
OBJECTIVE: To examine trends in the prevalence of conditions with a paradoxical (protective) relationship with mortality, and the impact of including these conditions on assessments of risk adjusted mortality.
METHODS: Patients age 65 and older admitted for acute myocardial infarction (AMI) or coronary artery bypass graft (CABG) surgery during 1994 through 2005 were identified in Medicare Part A files. Comorbid conditions defined using a common algorithm were categorized as having a paradoxical or non-paradoxical relationship with 30-day mortality, based upon regression coefficients in multivariable logistic regression models.
RESULTS: For AMI, the proportion of patients with one or more paradoxical condition and one or more non-paradoxical condition increased by 24% and 3% respectively between 1994 and 2005. The odds of death for patients with one-or-more paradoxical comorbidities, relative to patients with no paradoxical comorbidity, declined from 0.69 to 0.54 over the study period. In contrast, the risk associated with having one or more non-paradoxical comorbidities increased from 2.66 to 4.62 for AMI. This pattern was even stronger for CABG. Risk adjustment models that included paradoxical comorbidities found larger improvements, in risk-adjusted mortality for AMI and CABG, over time than models that did not include paradoxical comorbidities.
CONCLUSION: The relationship between individual comorbid conditions and mortality is changing over time, with potential impact on estimates of hospital performance and trends in mortality. Development of a standard approach for handling conditions with a paradoxical relationship to mortality is needed. Public Domain.

Entities:  

Mesh:

Year:  2011        PMID: 22340775      PMCID: PMC4010616          DOI: 10.5600/mmrr.001.03.a02

Source DB:  PubMed          Journal:  Medicare Medicaid Res Rev        ISSN: 2159-0354


  25 in total

Review 1.  Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data.

Authors:  Eric I Benchimol; Douglas G Manuel; Teresa To; Anne M Griffiths; Linda Rabeneck; Astrid Guttmann
Journal:  J Clin Epidemiol       Date:  2010-12-30       Impact factor: 6.437

2.  Assessing hospital-associated deaths from discharge data. The role of length of stay and comorbidities.

Authors:  S F Jencks; D K Williams; T L Kay
Journal:  JAMA       Date:  1988-10-21       Impact factor: 56.272

Review 3.  Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies.

Authors:  Abel Romero-Corral; Victor M Montori; Virend K Somers; Josef Korinek; Randal J Thomas; Thomas G Allison; Farouk Mookadam; Francisco Lopez-Jimenez
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

Review 4.  Using administrative data to study persons with disabilities.

Authors:  Lisa I Iezzoni
Journal:  Milbank Q       Date:  2002       Impact factor: 4.911

5.  The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH.

Authors:  Antigone Oreopoulos; Finlay A McAlister; Kamyar Kalantar-Zadeh; Raj Padwal; Justin A Ezekowitz; Arya M Sharma; Csaba P Kovesdy; Gregg C Fonarow; Colleen M Norris
Journal:  Eur Heart J       Date:  2009-07-16       Impact factor: 29.983

Review 6.  Administrative and claims records as sources of health care cost data.

Authors:  Gerald F Riley
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

7.  An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction.

Authors:  Harlan M Krumholz; Yun Wang; Jennifer A Mattera; Yongfei Wang; Lein Fang Han; Melvin J Ingber; Sheila Roman; Sharon-Lise T Normand
Journal:  Circulation       Date:  2006-03-20       Impact factor: 29.690

Review 8.  Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure.

Authors:  Kamyar Kalantar-Zadeh; Gladys Block; Tamara Horwich; Gregg C Fonarow
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

9.  Impact of different measures of comorbid disease on predicted mortality of intensive care unit patients.

Authors:  Joseph A Johnston; Douglas P Wagner; Stephen Timmons; Deborah Welsh; Joel Tsevat; Marta L Render
Journal:  Med Care       Date:  2002-10       Impact factor: 2.983

10.  Risk adjustment of Medicare capitation payments using the CMS-HCC model.

Authors:  Gregory C Pope; John Kautter; Randall P Ellis; Arlene S Ash; John Z Ayanian; Lisa I Lezzoni; Melvin J Ingber; Jesse M Levy; John Robst
Journal:  Health Care Financ Rev       Date:  2004
View more
  6 in total

1.  The Relative Ability of Comorbidity Ascertainment Methodologies to Predict In-Hospital Mortality Among Hospitalized Community-acquired Pneumonia Patients.

Authors:  Ronald E Weir; Christopher S Lyttle; David O Meltzer; Tien S Dong; Gregory W Ruhnke
Journal:  Med Care       Date:  2018-11       Impact factor: 2.983

2.  Utilization and Short-Term Outcomes of Primary Total Hip and Knee Arthroplasty in the United States and Canada: An Analysis of New York and Ontario Administrative Data.

Authors:  Peter Cram; Bruce E Landon; John Matelski; Vicki Ling; Therese A Stukel; J Michael Paterson; Rajiv Gandhi; Gillian A Hawker; Bheeshma Ravi
Journal:  Arthritis Rheumatol       Date:  2018-02-26       Impact factor: 10.995

3.  Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991-2010.

Authors:  Peter Cram; Xin Lu; Stephen L Kates; Jasvinder A Singh; Yue Li; Brian R Wolf
Journal:  JAMA       Date:  2012-09-26       Impact factor: 56.272

4.  Utilization of Advanced Cardiovascular Therapies in the United States and Canada: An Observational Study of New York and Ontario Administrative Data.

Authors:  Peter Cram; Saket Girotra; John Matelski; Maria Koh; Bruce E Landon; Lu Han; Douglas S Lee; Dennis T Ko
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-01-20

5.  Racial Differences in Hospital Death for Atrial Fibrillation: The National Inpatient Sample 2001-2012.

Authors:  Gene F Kwan; Danielle M Enserro; Emelia J Benjamin; Allan J Walkey; Renda Soylemez Wiener; Jared W Magnani
Journal:  Proclins Cardiol       Date:  2018-12-14

6.  Effect of the Diagnosis of Inflammatory Bowel Disease on Risk-Adjusted Mortality in Hospitalized Patients with Acute Myocardial Infarction, Congestive Heart Failure and Pneumonia.

Authors:  Eli D Ehrenpreis; Ying Zhou; Aimee Alexoff; Constantine Melitas
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.